Figs Inc (FIGS) Q1 2026 Earnings Call Transcript

Why It Matters

The results validate FIGS’ product‑centric growth model and international expansion, positioning the brand for sustained profitability amid a resilient healthcare apparel market.

Key Takeaways

• Revenue up 28% to $159.9M, driven by scrubwear
• Active customers exceed 3 million, 12% YoY growth
• International presence expands to 85 markets, revenue +50%
• Adjusted EBITDA margin improves to 8.7%, beating guidance
• Gross margin reaches 67.7% despite freight and tariff pressures

Pulse Analysis

FIGS’ first‑quarter performance underscores how a focused product strategy can translate into top‑line acceleration. The company’s core scrubwear line, now accounting for 79% of revenue, benefited from new fabric innovations such as FORMx and FIBREx, while non‑scrub categories delivered the strongest growth in three years. Coupled with a 4% rise in average order value, these dynamics reflect deeper penetration among higher‑spend customers and a successful rollout of seasonal color drops and limited‑edition collaborations that keep the brand fresh for healthcare professionals.

Profitability gains stem from disciplined cost management and pricing leverage. Despite higher inbound freight costs and tariff uncertainties, FIGS lifted its gross margin by ten basis points to 67.7% and flipped its operating margin to a positive 2.8%, driven by operational efficiencies and inventory optimization. The adjusted EBITDA margin of 8.7% outperformed internal guidance, highlighting the firm’s ability to absorb macro‑level headwinds while still delivering earnings growth. Inventory levels rose modestly, but the company’s target to cut inventory days to roughly 200 by year‑end signals a continued focus on working‑capital discipline.

Strategically, FIGS is betting on a hybrid digital‑first model complemented by physical community hubs and an expanding B2B "Teams" platform. International expansion accelerated, with revenue from 85 markets growing 50% and new market entries across Europe and Asia‑Pacific laying groundwork for long‑term scale. Raised guidance—14‑16% revenue growth and an operating‑margin target near 8%—reflects confidence in sustaining momentum. As the healthcare sector remains labor‑intensive and resilient, FIGS’ blend of brand storytelling, product innovation, and targeted institutional sales positions it to capture a larger share of the global medical apparel market.